Literature DB >> 32856470

Mobility and structural barriers in rural South Africa contribute to loss to follow up from HIV care.

Alisse Hannaford1, Anthony P Moll2,3, Thuthukani Madondo3, Bulelani Khoza3, Sheela V Shenoi4.   

Abstract

Retention in HIV care is crucial to sustaining viral load suppression, and reducing HIV transmission, yet loss to follow-up (LTFU) in South Africa remains substantial. We conducted a mixed methods evaluation in rural South Africa to characterize ART disengagement in neglected rural settings. Using convenience sampling, surveys were completed by 102 PLWH who disengaged from ART (minimum 90 days) and subsequently resumed care. A subset (n = 60) completed individual in-depth interviews. Median duration of ART discontinuation was 9 months (IQR 4-22). Participants had HIV knowledge gaps regarding HIV transmission and increased risk of tuberculosis. The major contributors to LTFU were mobility and structural barriers. PLWH traveled for an urgent family need or employment, and were not able to collect ART while away. Structural barriers included inability to access care, due to lack of financial resources to reach distant clinics. Other factors included dissatisfaction with care, pill fatigue, lack of social support, and stigma. Illness was the major precipitant of returning to care. Mobility and structural barriers impede longitudinal HIV care in rural South Africa, threatening the gains made from expanded ART access. To achieve 90-90-90, future interventions, including emphasis on patient centered care, must address barriers relevant to rural settings.

Entities:  

Keywords:  antiretroviral therapy; mobility; patient centered care; re-engagement; rural; structural barriers

Year:  2020        PMID: 32856470      PMCID: PMC8043244          DOI: 10.1080/09540121.2020.1808567

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  56 in total

1.  Evaluation of mHealth strategies to optimize adherence and efficacy of Option B+ prevention of mother-to-child HIV transmission: Rationale, design and methods of a 3-armed randomized controlled trial.

Authors:  Alison L Drake; Jennifer A Unger; Keshet Ronen; Daniel Matemo; Trevor Perrier; Brian DeRenzi; Barbra A Richardson; John Kinuthia; Grace John-Stewart
Journal:  Contemp Clin Trials       Date:  2017-03-14       Impact factor: 2.226

2.  Who starts antiretroviral therapy in Durban, South Africa?... not everyone who should.

Authors:  Ingrid V Bassett; Susan Regan; Senica Chetty; Janet Giddy; Lauren M Uhler; Helga Holst; Douglas Ross; Jeffrey N Katz; Rochelle P Walensky; Kenneth A Freedberg; Elena Losina
Journal:  AIDS       Date:  2010-01       Impact factor: 4.177

3.  Effect of Offering Same-Day ART vs Usual Health Facility Referral During Home-Based HIV Testing on Linkage to Care and Viral Suppression Among Adults With HIV in Lesotho: The CASCADE Randomized Clinical Trial.

Authors:  Niklaus D Labhardt; Isaac Ringera; Thabo I Lejone; Thomas Klimkait; Josephine Muhairwe; Alain Amstutz; Tracy R Glass
Journal:  JAMA       Date:  2018-03-20       Impact factor: 56.272

4.  Characteristics of and outcomes in HIV-infected patients who return to care after loss to follow-up.

Authors:  Bakhao Ndiaye; Karim Ould-Kaci; Julia Salleron; Pierre Bataille; Frederique Bonnevie; Karine Cochonat; Clotilde Fontier; Habib Guerroumi; Yazdan Yazdanpanah
Journal:  AIDS       Date:  2009-08-24       Impact factor: 4.177

5.  Loss to care and death before antiretroviral therapy in Durban, South Africa.

Authors:  Ingrid V Bassett; Bingxia Wang; Senica Chetty; Matilda Mazibuko; Benjamin Bearnot; Janet Giddy; Zhigang Lu; Elena Losina; Rochelle P Walensky; Kenneth A Freedberg
Journal:  J Acquir Immune Defic Syndr       Date:  2009-06-01       Impact factor: 3.731

Review 6.  Examining the associations between HIV-related stigma and health outcomes in people living with HIV/AIDS: a series of meta-analyses.

Authors:  Sergio Rueda; Sanjana Mitra; Shiyi Chen; David Gogolishvili; Jason Globerman; Lori Chambers; Mike Wilson; Carmen H Logie; Qiyun Shi; Sara Morassaei; Sean B Rourke
Journal:  BMJ Open       Date:  2016-07-13       Impact factor: 2.692

7.  Clinical decision tools are needed to identify HIV-positive patients at high risk for poor outcomes after initiation of antiretroviral therapy.

Authors:  Margaret L McNairy; Elaine J Abrams; Miriam Rabkin; Wafaa M El-Sadr
Journal:  PLoS Med       Date:  2017-04-18       Impact factor: 11.069

8.  Population mobility associated with higher risk sexual behaviour in eastern African communities participating in a Universal Testing and Treatment trial.

Authors:  Carol S Camlin; Adam Akullian; Torsten B Neilands; Monica Getahun; Patrick Eyul; Irene Maeri; Sarah Ssali; Elvin Geng; Monica Gandhi; Craig R Cohen; Moses R Kamya; Thomas Odeny; Elizabeth A Bukusi; Edwin D Charlebois
Journal:  J Int AIDS Soc       Date:  2018-07       Impact factor: 5.396

Review 9.  Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review.

Authors:  Katharina Kranzer; Darshini Govindasamy; Nathan Ford; Victoria Johnston; Stephen D Lawn
Journal:  J Int AIDS Soc       Date:  2012-11-19       Impact factor: 5.396

10.  Willingness to Act upon Beliefs about 'Treatment as Prevention' among Australian Gay and Bisexual Men.

Authors:  Benjamin R Bavinton; Martin Holt; Andrew E Grulich; Graham Brown; Iryna B Zablotska; Garrett P Prestage
Journal:  PLoS One       Date:  2016-01-07       Impact factor: 3.240

View more
  1 in total

1.  Uptake of community- versus clinic-based antiretroviral therapy dispensing in the Central Chronic Medication Dispensing and Distribution program in South Africa.

Authors:  Ingrid V Bassett; Joyce Yan; Sabina Govere; Anele Khumalo; Nompumelelo Ngobese; Zinhle Shazi; Mpilonhle Nzuza; Bridget A Bunda; Nafisa J Wara; Ashley Stuckwisch; Dani Zionts; Nduduzo Dube; Sandile Tshabalala; Laura M Bogart; Robert A Parker
Journal:  J Int AIDS Soc       Date:  2022-01       Impact factor: 5.396

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.